Home

Dr Lal Pathlabs Ltd EPS

Image

Dr Lal Pathlabs Ltd

NSE: LALPATHLAB

EPS

₹ 49.86

Last updated on: Apr 03, 2025

Key Highlights

  • The Earning per Share of Dr Lal Pathlabs Ltd is ₹ 49.86 as of 03 Apr 25 .
  • The earning per share of Dr Lal Pathlabs Ltd changed from ₹ 9.95 to ₹ 11.6 over 7 quarters. This represents a CAGR of 9.16% .

Historical Earning per Share of Dr Lal Pathlabs Ltd

No data available

* All values are in

Company Fundamentals for Dr Lal Pathlabs Ltd

Market Cap

21,017 Cr

EPS

49.9

P/E Ratio (TTM)

50.4

P/B Ratio (TTM)

10.5

Day’s High

2576.5

Day’s Low

2466.0

DTE

0.1

ROE

20.1

52 Week High

3645.0

52 Week Low

2168.8

ROCE

27.0

Market Price of Dr Lal Pathlabs Ltd

1M

1Y

3Y

5Y

Monitoring Dr Lal Pathlabs Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Market Price

Date
leftPrice (₹)right
03 Apr 20252514.35
02 Apr 20252498.6
01 Apr 20252403.25
28 Mar 20252478.1
27 Mar 20252499.45
26 Mar 20252445.5
25 Mar 20252503.55
24 Mar 20252489.65
21 Mar 20252531.45
20 Mar 20252515.7

SWOT Analysis Of Dr Lal Pathlabs Ltd

Strength

6

che

Weakness

2

che

Opportunity

0

che

Threats

1

che

BlinkX Score for Dr Lal Pathlabs Ltd

Asset Value vs Market Value of Dr Lal Pathlabs Ltd

Market Value

21,018

Asset Value

Value addition

18.9 X

1,058

* All values are in ₹ crores

Competitive Comparison of EPS

Company
leftMarket Capright
Dr Lal Pathlabs Ltd21017
Max Healthcare Institute Ltd109021
Apollo Hospitals Enterprise Ltd95889
Fortis Healthcare Ltd49823
Narayana Hrudayalaya Ltd34030
Global Health Ltd33305

Historical Market Cap of Dr Lal Pathlabs Ltd

No data available

* All values are in crore

Historical Revenue of Dr Lal Pathlabs Ltd

No data available

* All values are in crore

Historical EBITDA of Dr Lal Pathlabs Ltd

No data available

* All values are in crore

Historical Net Profit of Dr Lal Pathlabs Ltd

No data available

* All values are in crore

Dividend Payout Over Time

No data available

Dr Lal Pathlabs Ltd News Hub

Dr Lal Pathlabs allots 93,900 equity shares under ESOP

Dr Lal Pathlabs has allotted 93,900 equity shares under Dr. Lal PathLabs Employee Stock Option Plan,

Read more

13 Aug 24

Board of Dr. Lal PathLabs recommends interim dividend

Dr. Lal PathLabs announced that the Board of Directors of the Company at its meeting held on 7 Augus

Read more

07 Aug 24

Dr Lal Pathlabs consolidated net profit rises 28.81% in the June 2024 quarter

Net profit of Dr Lal Pathlabs rose 28.81% to Rs 106.40 crore in the quarter ended June 2024 as again

Read more

07 Aug 24

Dr Lal PathLabs gains after Q1 PAT rises 29% YoY to Rs 108 cr

Revenue from operations increased 11.26% YoY to Rs 601.9 crore during the quarter. Profit before tax

Read more

07 Aug 24

Document

Annual Reports

Annual Report 2024

dropdown
download

Credit Ratings

Credit Report 2024

dropdown
download

Concalls

Oct 2024

PPT

July 2023

PPT

July 2021

Transcript

June 2021

TranscriptPPT

May 2021

PPT

Jan 2021

PPT

FAQs for EPS of Dr Lal Pathlabs Ltd

What is the EPS of Dr Lal Pathlabs Ltd stock?

The Earnings Per Share (EPS) of Dr Lal Pathlabs Ltd is 49.86. An EPS is the amount of net income attributed to each share of a common stock.

How is Dr Lal Pathlabs Ltd EPS calculated?

The EPS of Dr Lal Pathlabs Ltd is calculated by dividing the net income by the number of outstanding shares. The formula is EPS = (Net Income - Dividends on Preferred Stock) / Average Outstanding Shares.

How often does Dr Lal Pathlabs Ltd report its EPS?

Dr Lal Pathlabs Ltd typically reports its EPS quarterly and annually, in conjunction with its financial statements and earnings reports.

What factors can influence Dr Lal Pathlabs Ltd EPS?

Factors that influence the EPS of Dr Lal Pathlabs Ltd include revenue changes, cost fluctuations, operational efficiency, tax rates, and one-time gains or losses.

Can Dr Lal Pathlabs Ltd EPS growth indicate future performance?

Yes, consistent growth in Dr Lal Pathlabs Ltd EPS can suggest strong financial health and effective management, potentially indicating positive future performance.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions